Supreme Court of the United States
Warner-Jenkinson Co., Inc. v. Hilton Davis Chemical Co.
March 3, 1997520 U.S. 17
Summary
Justice Thomas delivered the Court’s opinion preserving the doctrine of equivalents while requiring an objective, element-by-element infringement inquiry that does not eliminate any claim element. The Court held that prosecution history estoppel depends on the reason for a required claim amendment; the patentee must establish that reason, and an unexplained amendment is presumed to rest on a substantial reason related to patentability. Intent is irrelevant, and equivalence is assessed at the time of infringement rather than patent issuance. The Court declined to prescribe a single verbal test for equivalence or decide the allocation of equivalence determinations between judge and jury. It reversed the Federal Circuit’s judgment and remanded for application of these requirements. No separate opinion appears in the supplied text.
Holding
- Survival of the doctrine of equivalents under the 1952 Patent Act.. The doctrine of equivalents remains available under the 1952 Patent Act.
- The proper unit of comparison for equivalence.. Equivalence must be assessed element by element, not by comparing the accused product or process with the patented invention as a whole, and cannot effectively eliminate a claim element.
- Prosecution history estoppel and unexplained claim amendments.. A required claim amendment does not automatically foreclose equivalents regardless of its reason. The patentee bears the burden of establishing the reason, and an unexplained amendment is presumed to have a substantial patentability-related purpose that triggers estoppel.
- The role of intent in infringement by equivalents.. Intent plays no role in applying the doctrine of equivalents.
- The relevant time for assessing equivalence.. Equivalence is assessed at the time of infringement; equivalents need not have been known or disclosed when the patent issued.
- The appropriate verbal test for equivalence.. No single linguistic formulation is required; the essential inquiry is whether the accused product or process contains an identical or equivalent counterpart to every claimed element.
Docket 95-728
Cited authorities
- 35 U.S.C. § 100
- 35 U.S.C. § 112
- 16 Stat. 198
Cited by
- (PC) Gardner v. Vallejo Police Department
- (PC) Burton v. Foulk
- Everyscape, Inc. v. Adobe Systems, Inc.
- Everyscape, Inc. v. Adobe Systems, Inc.
- Metris U.S.A., Inc., Metris N.v., Metris Ipr N.v., and 3d Scanners Ltd. v. Faro Technologies, Inc.
- Cabot Safety Intermediate Corporation v. Howard S. Leight and Associates, Inc.
- Purdue Pharma, L.p. v. Collegium Pharmaceutical, Inc. Lead Case
- Ohio State Innovation Foundation v. Akamai Technologies, Inc.